Trial Profile
A phase II study of Alimta [pemetrexed] and carboplatin in the treatment of patients with locally advanced or metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2006
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 28 Jul 2006 Status change
- 04 Sep 2005 New trial record.